Literature DB >> 49388

Immunological analysis of plasminogen activators from normal and transformed hamster cells. Evidence that the plasminogen activators produced by SV40 virus-transformed hamster embryo cells and normal hamster lung cells are antigenically identical.

J K Christman, S C Silverstein, G Acs.   

Abstract

Rabbits were immunized against the plasminogen activator released by SV4- virus-transformed hamster embryo cells. The resulting antiplasminogen activator immunoglobulin (APA-IgG) inhibited the enzymatic activity of the plasminogen activator produced by SV40-transformed hamster cells, and the plasmin-catalyzed release of these cells from the tissue culture dish. APA-IgG was not cytotoxic for these cells even in the presence of complement and did not inhibit their release of plasminogen activator. APA-IgG formed a single precipitin line in immunodiffusion plates using highly purified plasminogen activator as antigen. APA-IgG inhibited the plasminogen activator produced by newborn hamster lung cells and by an established diploid line (DON) of hamster lung cells, but did not inhibit plasminogen activators produced by normal or transformed hamster kidney cells or by cells of other species (mouse and human). We derive three major conclusions from these data: (a) There are several immunologically distinguishable forms (isozymes) of plasminogen activators in normal hamster tissues. (b) The plasminogen activators produced by normal hamster lung cells and by SV40 virus-transformed hamster embryo cells share antigenic determinants and are presumably the same isozyme. (c) The plasminogen activators produced by different hamster tumor cells do not share antigenic determinants and are presumably different isozymes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 49388      PMCID: PMC2189904          DOI: 10.1084/jem.142.2.419

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  MULTIPLE FORMS OF ENZYMES: TISSUE, ONTOGENETIC, AND SPECIES SPECIFIC PATTERNS.

Authors:  C L Markert; F Møller
Journal:  Proc Natl Acad Sci U S A       Date:  1959-05       Impact factor: 11.205

2.  Amino acid sequences of proinsulins and intermediates.

Authors:  R E Chance
Journal:  Diabetes       Date:  1972       Impact factor: 9.461

3.  Dissimilarity of human vascular plasminogen activator and human urokinase.

Authors:  N Aoki; K N Von Kaulla
Journal:  J Lab Clin Med       Date:  1971-09

4.  Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells.

Authors:  J K Christman; S Silagi; E W Newcomb; S C Silverstein; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

5.  Tumorigenicity, immunogenicity, and virus production in mouse melanoma cells treated with 5-bromodeoxyuridine.

Authors:  S Silagi; D Beju; J Wrathall; E Deharven
Journal:  Proc Natl Acad Sci U S A       Date:  1972-11       Impact factor: 11.205

6.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

7.  Segmental response of the macrophage plasma membrane to a phagocytic stimulus.

Authors:  F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

8.  Properties of plasminogen activators formed by neoplastic human cell cultures.

Authors:  D B Rifkin; J N Loeb; G Moore; E Reich
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

9.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses.

Authors:  L Ossowski; J C Unkeless; A Tobia; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

10.  Immunoglobulin and other surface antigens of cells of the immune system.

Authors:  T Takahashi; L J Old; K R McIntire; E A Boyse
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

View more
  7 in total

1.  Protease effects on specific growth properties of normal and transformed baby hamster kidney cells.

Authors:  M Brown; D Kiehn
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

2.  Immunological analysis of plasminogen activators from cultured human cancer cells.

Authors:  S Naito; K Sueishi; F Hattori; K Tanaka
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

3.  Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification.

Authors:  L S Nielsen; J G Hansen; P A Andreasen; L Skriver; K Danø; J Zeuthen
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

4.  Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody.

Authors:  P A Andreasen; L S Nielsen; J Grøndahl-Hansen; L Skriver; J Zeuthen; R W Stephens; K Danø
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598

5.  Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse.

Authors:  L I Larsson; L Skriver; L S Nielsen; J Grøndahl-Hansen; P Kristensen; K Danø
Journal:  J Cell Biol       Date:  1984-03       Impact factor: 10.539

6.  Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma.

Authors:  L Skriver; L I Larsson; V Kielberg; L S Nielsen; P B Andresen; P Kristensen; K Danø
Journal:  J Cell Biol       Date:  1984-08       Impact factor: 10.539

7.  Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.

Authors:  E G Levin; D J Loskutoff
Journal:  J Cell Biol       Date:  1982-09       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.